Healthcare & Pharmaceuticals
🟢 SERP-Grounded (Light Telemetry)
Advanced Cell Diagnostics
Programmatic AI Search & Model Visibility Audit
Share of Model (SOM)The percentage of time frontier AI models (ChatGPT, Claude, Gemini) recommend this brand for high-intent category queries.
0.1%
+0.0% 30-Day MomentumThe rolling 30-day change in algorithmic Share of Model. Positive momentum indicates increasing AI mindshare.
🧠 Neural Valency:VulnerableThe contextual sentiment of the AI's recommendation. 'Dominant' implies strong conviction, while 'Vulnerable' implies the model heavily conditions its recommendation.
Algorithmic Threat Detection
Primary Competitor Threat
Bio-Techne
Competitor Displacement Rate
0.1%
Competitors are displacing Advanced Cell Diagnostics in 0.1% of high-intent buyer queries.The frequency at which AI models actively suggest a competitor as a superior alternative to this brand.
Algorithmic Rationale: Competitors offer a wider range of advanced cell analysis tools and integrated platforms, leading to greater visibility in specific research areas.
Missing AI Citations:High-authority domains (e.g., Reddit, G2) that models cite to justify recommending competitors, where this brand currently lacks presence.
[biotechne.com][thermofisher.com][cellsignal.com]⚠️ Identified Vulnerability:Product Breadth
Primary Threat Identified:Bio-Techne
Target Persona:Molecular Biologists
🚨 Threat Velocity:6/10An algorithmic urgency score (1-10) indicating how rapidly competitors are capturing this brand's historical AI search share.
Unlock Full Threat Report (30 Free Credits)